Successfully reported this slideshow.
Your SlideShare is downloading. ×

Pervasive Neurotechnology: The Digital Revolution Meets the Human Brain

Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad

Check these out next

1 of 24 Ad

Pervasive Neurotechnology: The Digital Revolution Meets the Human Brain

Slidedeck from June 30th, 2015 webinar, with Alvaro Fernandez and Nikhil Sriraman. to dis­cuss the key take-aways from the new mar­ket report Per­va­sive Neu­rotech­nol­ogy: A Ground­break­ing Analy­sis of 10,000+ Patent Fil­ings Trans­form­ing Med­i­cine, Health, Enter­tain­ment and Busi­ness. To learn more: http://sharpbrains.com/pervasive-neurotechnology/

Agenda:
1–1.20pm ET: Five Key Trends Dri­ving Neu­rotech­nol­ogy to Become Pervasive
1.20–1.40pm ET: How Nielsen, Advanced Neu­ro­mod­u­la­tion Sys­tems, Medtronic, Microsoft and Brain­lab emerged as lead­ing IP Holders
1.40-2pm ET: Q&A

Slidedeck from June 30th, 2015 webinar, with Alvaro Fernandez and Nikhil Sriraman. to dis­cuss the key take-aways from the new mar­ket report Per­va­sive Neu­rotech­nol­ogy: A Ground­break­ing Analy­sis of 10,000+ Patent Fil­ings Trans­form­ing Med­i­cine, Health, Enter­tain­ment and Busi­ness. To learn more: http://sharpbrains.com/pervasive-neurotechnology/

Agenda:
1–1.20pm ET: Five Key Trends Dri­ving Neu­rotech­nol­ogy to Become Pervasive
1.20–1.40pm ET: How Nielsen, Advanced Neu­ro­mod­u­la­tion Sys­tems, Medtronic, Microsoft and Brain­lab emerged as lead­ing IP Holders
1.40-2pm ET: Q&A

Advertisement
Advertisement

More Related Content

Slideshows for you (20)

Similar to Pervasive Neurotechnology: The Digital Revolution Meets the Human Brain (20)

Advertisement

More from SharpBrains (18)

Recently uploaded (20)

Advertisement

Pervasive Neurotechnology: The Digital Revolution Meets the Human Brain

  1. 1. The Digital Revolution Meets The Human Brain = Pervasive Neurotech
  2. 2. The team behind the new Pervasive Neurotechnology report Alvaro Fernandez Editor-In-Chief Nikhil Sriraman IP Analyst Brian Gurewitz Technology Analyst Olivier Oullier Science Advisor
  3. 3. Today’s Agenda  1-1.20pm ET: Five Key Trends Driving Neurotechnology to Become Pervasive  1.20-1.40pm ET: How Nielsen, Advanced Neuromodulation Systems, Medtronic, Microsoft and Brainlab emerged as leading IP Holders  1.40-2pm ET: Q&A
  4. 4. Five key trends and insights 1. Exponential growth since 2010, close to/ supporting commercialization 2. Large companies developing significant portfolios, often under the radar 3. Evolution from invasive to pervasive  impact on medicine, health, entertainment and business 4. Multi-sensor, multi-variable analysis and use of data (EEG, eye-tracking, heart rate, computer use, patient…) 5. Aggressive “build” AND strategic/ tactical “buy”
  5. 5. Today’s Agenda  1-1.20pm ET: Five Key Trends Driving Neurotechnology to Become Pervasive  1.20-1.40pm ET: How Nielsen, Advanced Neuromodulation Systems, Medtronic, Microsoft and Brainlab emerged as leading IP Holders  1.40-2pm ET: Q&A
  6. 6. How we identified the population of non-invasive neurotech patent filings 4K+ US non-invasive neurotech patents 10K+ GLOBAL pubs yielded w/ similar process
  7. 7. How we assessed patent portfolios The SharpBrains’ IP Strength Index: Quantity + Quality Volume + Relevance Fwd Cites + Scope + Key Patents
  8. 8. IP portfolio strength of 800+ organizations assessed via SharpBrains Index (Report includes detailed profiles of top 30, and ranks top 100) How the Leading IP Holders emerged
  9. 9. #1: Nielsen (NYSE:NLSN)
  10. 10. #1: Nielsen (NYSE:NLSN)
  11. 11. #2: Advanced Neuromodulation Systems (St Jude Medical -- NYSE: STJ)
  12. 12. #3: Medtronic (NYSE:MDT)
  13. 13. #4: Microsoft (NASDAQ:MSFT)
  14. 14. #4: Microsoft (NASDAQ:MSFT)
  15. 15. #5: Brainlab
  16. 16. 206-page report includes  Chapter I. Scoping the Opportunity  Chapter II. The State of Pervasive Neurotechnology Patents  Chapter III. The Patent Holders: Ranking of Top 100 Assignees, and Detailed Profiles of 30 Leaders  Chapter IV. Analysis of 50 key Active Patents  Check out the full Table of Contents & Figures

×